cd81 primary antibody Search Results


90
Cosmo Bio USA anti-cd81 shi-exo-m03
Anti Cd81 Shi Exo M03, supplied by Cosmo Bio USA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-cd81 shi-exo-m03/product/Cosmo Bio USA
Average 90 stars, based on 1 article reviews
anti-cd81 shi-exo-m03 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

91
Santa Cruz Biotechnology rabbit polyclonal antibody anti cd81
Rabbit Polyclonal Antibody Anti Cd81, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal antibody anti cd81/product/Santa Cruz Biotechnology
Average 91 stars, based on 1 article reviews
rabbit polyclonal antibody anti cd81 - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

90
Becton Dickinson cd81
Liver organoids grow from HCV-infected individuals and show similar differentiation potential. ( A ) Representative brightfield microscopy images of liver organoids grown from uninfected (NV) or HCV + donors are shown in the stem cell (EM) and differentiated (DM) states. Organoids are morphologically distinct in EM vs DM states, but each state was morphologically identical across all six NV and HCV + donors. ( B ) Quantitative PCR (qPCR) quantification of hepatocyte stem cell marker LGR5 and hepatocyte markers ALB, CYP3A4, and CYP2B6 in DM organoids from three NV donors and three HCV + donors, and in two primary hepatocyte samples relative to EM. For each gene, data were pooled from n ≥ 2 biological replicates per organoid or hepatocyte donor and represented as mean ± SD. Transcript expression was normalized to 18S and plotted as a fold change over the gene’s expression in EM (ΔΔC T ) which was set to one and is marked by a dotted line. Fold change was plotted on a log10 scale. ( C ) qPCR quantification of HCV entry markers, <t>CD81,</t> OCLN, CLDN1, and SR-B1 in the same samples as in ( B ). EM expression levels were set to one (marked by a dotted line), and fold change in DM was plotted on a linear scale. ( D ) Representative light-sheet microscopy images are shown for differentiated liver organoids (DM) stained for hepatocyte markers HNF4α and ALB, HCV entry factors CLDN1 and CD81, or apical membrane marker ZO1.
Cd81, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd81/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
cd81 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

96
Proteintech anti cd81
Liver organoids grow from HCV-infected individuals and show similar differentiation potential. ( A ) Representative brightfield microscopy images of liver organoids grown from uninfected (NV) or HCV + donors are shown in the stem cell (EM) and differentiated (DM) states. Organoids are morphologically distinct in EM vs DM states, but each state was morphologically identical across all six NV and HCV + donors. ( B ) Quantitative PCR (qPCR) quantification of hepatocyte stem cell marker LGR5 and hepatocyte markers ALB, CYP3A4, and CYP2B6 in DM organoids from three NV donors and three HCV + donors, and in two primary hepatocyte samples relative to EM. For each gene, data were pooled from n ≥ 2 biological replicates per organoid or hepatocyte donor and represented as mean ± SD. Transcript expression was normalized to 18S and plotted as a fold change over the gene’s expression in EM (ΔΔC T ) which was set to one and is marked by a dotted line. Fold change was plotted on a log10 scale. ( C ) qPCR quantification of HCV entry markers, <t>CD81,</t> OCLN, CLDN1, and SR-B1 in the same samples as in ( B ). EM expression levels were set to one (marked by a dotted line), and fold change in DM was plotted on a linear scale. ( D ) Representative light-sheet microscopy images are shown for differentiated liver organoids (DM) stained for hepatocyte markers HNF4α and ALB, HCV entry factors CLDN1 and CD81, or apical membrane marker ZO1.
Anti Cd81, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd81/product/Proteintech
Average 96 stars, based on 1 article reviews
anti cd81 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

90
ProSci Incorporated antibodies against cd81
Figure 1. Characterization of miR-185 enriched MSC-EVs. (A) Isolated miR-185 MSC-EVs were characterized by TEM. Representative image is shown (scale bar ¼ 50 nm). (B) NTA was performed on the EVs to determine their concentration and size. EV diameter was measured and represented as mean ± SD, n ¼ 3 independent experiments performed in triplicate. Western blotting (insets) for EV markers CD9, <t>CD81</t> and flotillin-1. (C) qPCR analysis for expression of miR-185 in EVs. n ¼ 5 inde- pendent experiments performed in triplicate (p < .01 versus Ctrl).
Antibodies Against Cd81, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against cd81/product/ProSci Incorporated
Average 90 stars, based on 1 article reviews
antibodies against cd81 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GeneTex cd81 gtx31381 antibody
Figure 1. Characterization of miR-185 enriched MSC-EVs. (A) Isolated miR-185 MSC-EVs were characterized by TEM. Representative image is shown (scale bar ¼ 50 nm). (B) NTA was performed on the EVs to determine their concentration and size. EV diameter was measured and represented as mean ± SD, n ¼ 3 independent experiments performed in triplicate. Western blotting (insets) for EV markers CD9, <t>CD81</t> and flotillin-1. (C) qPCR analysis for expression of miR-185 in EVs. n ¼ 5 inde- pendent experiments performed in triplicate (p < .01 versus Ctrl).
Cd81 Gtx31381 Antibody, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd81 gtx31381 antibody/product/GeneTex
Average 90 stars, based on 1 article reviews
cd81 gtx31381 antibody - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

cd8  (Abcam)
99
Abcam cd8
Exo repress immune escape and immunosuppression in PDAC. (A) The protein expression of PD-L1 and CTLA-4 in PDAC cells treated with PBS or Exo. (B) Co-culture Exo- or PBS-treated PDAC cells with activated T cells. (C) Surviving PDAC cells examined using crystal violet staining. (D) The levels of IFN-γ and TNF-α, the immune effectors released by T cells, examined by ELISA. (E) Volume changes of xenograft tumors. (F) Weight of xenograft tumors. (G) Immunohistochemical detection of <t>CD8+</t> T cell infiltration and expression of PD-L1 and CTLA-4 in xenograft tumors. *P < 0.05. Data are shown as mean ± SD of three technical replicates (n = 5). Unpaired t-test (F) and two-way ANOVA (A, C-E, G) were used for data comparison.
Cd8, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd8/product/Abcam
Average 99 stars, based on 1 article reviews
cd8 - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

90
ABclonal Biotechnology cd9 primary antibody
Exo repress immune escape and immunosuppression in PDAC. (A) The protein expression of PD-L1 and CTLA-4 in PDAC cells treated with PBS or Exo. (B) Co-culture Exo- or PBS-treated PDAC cells with activated T cells. (C) Surviving PDAC cells examined using crystal violet staining. (D) The levels of IFN-γ and TNF-α, the immune effectors released by T cells, examined by ELISA. (E) Volume changes of xenograft tumors. (F) Weight of xenograft tumors. (G) Immunohistochemical detection of <t>CD8+</t> T cell infiltration and expression of PD-L1 and CTLA-4 in xenograft tumors. *P < 0.05. Data are shown as mean ± SD of three technical replicates (n = 5). Unpaired t-test (F) and two-way ANOVA (A, C-E, G) were used for data comparison.
Cd9 Primary Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd9 primary antibody/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
cd9 primary antibody - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

96
Proteintech cd8
Exo repress immune escape and immunosuppression in PDAC. (A) The protein expression of PD-L1 and CTLA-4 in PDAC cells treated with PBS or Exo. (B) Co-culture Exo- or PBS-treated PDAC cells with activated T cells. (C) Surviving PDAC cells examined using crystal violet staining. (D) The levels of IFN-γ and TNF-α, the immune effectors released by T cells, examined by ELISA. (E) Volume changes of xenograft tumors. (F) Weight of xenograft tumors. (G) Immunohistochemical detection of <t>CD8+</t> T cell infiltration and expression of PD-L1 and CTLA-4 in xenograft tumors. *P < 0.05. Data are shown as mean ± SD of three technical replicates (n = 5). Unpaired t-test (F) and two-way ANOVA (A, C-E, G) were used for data comparison.
Cd8, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd8/product/Proteintech
Average 96 stars, based on 1 article reviews
cd8 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc cd81
Exo repress immune escape and immunosuppression in PDAC. (A) The protein expression of PD-L1 and CTLA-4 in PDAC cells treated with PBS or Exo. (B) Co-culture Exo- or PBS-treated PDAC cells with activated T cells. (C) Surviving PDAC cells examined using crystal violet staining. (D) The levels of IFN-γ and TNF-α, the immune effectors released by T cells, examined by ELISA. (E) Volume changes of xenograft tumors. (F) Weight of xenograft tumors. (G) Immunohistochemical detection of <t>CD8+</t> T cell infiltration and expression of PD-L1 and CTLA-4 in xenograft tumors. *P < 0.05. Data are shown as mean ± SD of three technical replicates (n = 5). Unpaired t-test (F) and two-way ANOVA (A, C-E, G) were used for data comparison.
Cd81, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd81/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
cd81 - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

90
GeneTex primary antibodies to cd9 gtx76182
Exo repress immune escape and immunosuppression in PDAC. (A) The protein expression of PD-L1 and CTLA-4 in PDAC cells treated with PBS or Exo. (B) Co-culture Exo- or PBS-treated PDAC cells with activated T cells. (C) Surviving PDAC cells examined using crystal violet staining. (D) The levels of IFN-γ and TNF-α, the immune effectors released by T cells, examined by ELISA. (E) Volume changes of xenograft tumors. (F) Weight of xenograft tumors. (G) Immunohistochemical detection of <t>CD8+</t> T cell infiltration and expression of PD-L1 and CTLA-4 in xenograft tumors. *P < 0.05. Data are shown as mean ± SD of three technical replicates (n = 5). Unpaired t-test (F) and two-way ANOVA (A, C-E, G) were used for data comparison.
Primary Antibodies To Cd9 Gtx76182, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies to cd9 gtx76182/product/GeneTex
Average 90 stars, based on 1 article reviews
primary antibodies to cd9 gtx76182 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
ABclonal Biotechnology primary antibodies ifn-γ
Exo repress immune escape and immunosuppression in PDAC. (A) The protein expression of PD-L1 and CTLA-4 in PDAC cells treated with PBS or Exo. (B) Co-culture Exo- or PBS-treated PDAC cells with activated T cells. (C) Surviving PDAC cells examined using crystal violet staining. (D) The levels of IFN-γ and TNF-α, the immune effectors released by T cells, examined by ELISA. (E) Volume changes of xenograft tumors. (F) Weight of xenograft tumors. (G) Immunohistochemical detection of <t>CD8+</t> T cell infiltration and expression of PD-L1 and CTLA-4 in xenograft tumors. *P < 0.05. Data are shown as mean ± SD of three technical replicates (n = 5). Unpaired t-test (F) and two-way ANOVA (A, C-E, G) were used for data comparison.
Primary Antibodies Ifn γ, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies ifn-γ/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
primary antibodies ifn-γ - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Liver organoids grow from HCV-infected individuals and show similar differentiation potential. ( A ) Representative brightfield microscopy images of liver organoids grown from uninfected (NV) or HCV + donors are shown in the stem cell (EM) and differentiated (DM) states. Organoids are morphologically distinct in EM vs DM states, but each state was morphologically identical across all six NV and HCV + donors. ( B ) Quantitative PCR (qPCR) quantification of hepatocyte stem cell marker LGR5 and hepatocyte markers ALB, CYP3A4, and CYP2B6 in DM organoids from three NV donors and three HCV + donors, and in two primary hepatocyte samples relative to EM. For each gene, data were pooled from n ≥ 2 biological replicates per organoid or hepatocyte donor and represented as mean ± SD. Transcript expression was normalized to 18S and plotted as a fold change over the gene’s expression in EM (ΔΔC T ) which was set to one and is marked by a dotted line. Fold change was plotted on a log10 scale. ( C ) qPCR quantification of HCV entry markers, CD81, OCLN, CLDN1, and SR-B1 in the same samples as in ( B ). EM expression levels were set to one (marked by a dotted line), and fold change in DM was plotted on a linear scale. ( D ) Representative light-sheet microscopy images are shown for differentiated liver organoids (DM) stained for hepatocyte markers HNF4α and ALB, HCV entry factors CLDN1 and CD81, or apical membrane marker ZO1.

Journal: mBio

Article Title: Hepatitis C virus infects and perturbs liver stem cells

doi: 10.1128/mbio.01318-23

Figure Lengend Snippet: Liver organoids grow from HCV-infected individuals and show similar differentiation potential. ( A ) Representative brightfield microscopy images of liver organoids grown from uninfected (NV) or HCV + donors are shown in the stem cell (EM) and differentiated (DM) states. Organoids are morphologically distinct in EM vs DM states, but each state was morphologically identical across all six NV and HCV + donors. ( B ) Quantitative PCR (qPCR) quantification of hepatocyte stem cell marker LGR5 and hepatocyte markers ALB, CYP3A4, and CYP2B6 in DM organoids from three NV donors and three HCV + donors, and in two primary hepatocyte samples relative to EM. For each gene, data were pooled from n ≥ 2 biological replicates per organoid or hepatocyte donor and represented as mean ± SD. Transcript expression was normalized to 18S and plotted as a fold change over the gene’s expression in EM (ΔΔC T ) which was set to one and is marked by a dotted line. Fold change was plotted on a log10 scale. ( C ) qPCR quantification of HCV entry markers, CD81, OCLN, CLDN1, and SR-B1 in the same samples as in ( B ). EM expression levels were set to one (marked by a dotted line), and fold change in DM was plotted on a linear scale. ( D ) Representative light-sheet microscopy images are shown for differentiated liver organoids (DM) stained for hepatocyte markers HNF4α and ALB, HCV entry factors CLDN1 and CD81, or apical membrane marker ZO1.

Article Snippet: Primary antibodies we used include CD81 (BD Pharmigen, JS-81), claudin-1 (Thermo Scientific, 2H10D10), HNF4α (Cell Signaling Technology, C11F12), albumin (Sigma-Aldrich, HSA-11), and ZO1 (Thermo Scientific, 1A12).

Techniques: Infection, Microscopy, Real-time Polymerase Chain Reaction, Marker, Expressing, Staining, Membrane

Figure 1. Characterization of miR-185 enriched MSC-EVs. (A) Isolated miR-185 MSC-EVs were characterized by TEM. Representative image is shown (scale bar ¼ 50 nm). (B) NTA was performed on the EVs to determine their concentration and size. EV diameter was measured and represented as mean ± SD, n ¼ 3 independent experiments performed in triplicate. Western blotting (insets) for EV markers CD9, CD81 and flotillin-1. (C) qPCR analysis for expression of miR-185 in EVs. n ¼ 5 inde- pendent experiments performed in triplicate (p < .01 versus Ctrl).

Journal: Artificial cells, nanomedicine, and biotechnology

Article Title: Delivery of mesenchymal stem cells-derived extracellular vesicles with enriched miR-185 inhibits progression of OPMD.

doi: 10.1080/21691401.2019.1623232

Figure Lengend Snippet: Figure 1. Characterization of miR-185 enriched MSC-EVs. (A) Isolated miR-185 MSC-EVs were characterized by TEM. Representative image is shown (scale bar ¼ 50 nm). (B) NTA was performed on the EVs to determine their concentration and size. EV diameter was measured and represented as mean ± SD, n ¼ 3 independent experiments performed in triplicate. Western blotting (insets) for EV markers CD9, CD81 and flotillin-1. (C) qPCR analysis for expression of miR-185 in EVs. n ¼ 5 inde- pendent experiments performed in triplicate (p < .01 versus Ctrl).

Article Snippet: MSC-EVs were probed with primary antibodies against CD81 (1:400 dilution, ProSci, Collins, CO), CD9 (1:300 dilution, Lifespan Bioscience Inc., Seattle, WA) and flotillin-1 (1:500 dilution, Abcam, Cambridge, MA) by Western blotting.

Techniques: Isolation, Concentration Assay, Western Blot, Expressing

Exo repress immune escape and immunosuppression in PDAC. (A) The protein expression of PD-L1 and CTLA-4 in PDAC cells treated with PBS or Exo. (B) Co-culture Exo- or PBS-treated PDAC cells with activated T cells. (C) Surviving PDAC cells examined using crystal violet staining. (D) The levels of IFN-γ and TNF-α, the immune effectors released by T cells, examined by ELISA. (E) Volume changes of xenograft tumors. (F) Weight of xenograft tumors. (G) Immunohistochemical detection of CD8+ T cell infiltration and expression of PD-L1 and CTLA-4 in xenograft tumors. *P < 0.05. Data are shown as mean ± SD of three technical replicates (n = 5). Unpaired t-test (F) and two-way ANOVA (A, C-E, G) were used for data comparison.

Journal: American Journal of Cancer Research

Article Title: Circ_0006790 carried by bone marrow mesenchymal stem cell-derived exosomes regulates S100A11 DNA methylation through binding to CBX7 in pancreatic ductal adenocarcinoma

doi:

Figure Lengend Snippet: Exo repress immune escape and immunosuppression in PDAC. (A) The protein expression of PD-L1 and CTLA-4 in PDAC cells treated with PBS or Exo. (B) Co-culture Exo- or PBS-treated PDAC cells with activated T cells. (C) Surviving PDAC cells examined using crystal violet staining. (D) The levels of IFN-γ and TNF-α, the immune effectors released by T cells, examined by ELISA. (E) Volume changes of xenograft tumors. (F) Weight of xenograft tumors. (G) Immunohistochemical detection of CD8+ T cell infiltration and expression of PD-L1 and CTLA-4 in xenograft tumors. *P < 0.05. Data are shown as mean ± SD of three technical replicates (n = 5). Unpaired t-test (F) and two-way ANOVA (A, C-E, G) were used for data comparison.

Article Snippet: The sections were sealed with 5% BSA at 37°C for 30 min and incubated overnight at 4°C with primary antibodies to CD8 (1:2000, ab209775, Abcam), PD-L1 (1:1.000, ab237726, Abcam), and CTLA-4 (1:500, ab237712, Abcam).

Techniques: Expressing, Co-Culture Assay, Staining, Enzyme-linked Immunosorbent Assay, Immunohistochemical staining

The circ_6790/CBX7/S100A11 axis regulates immune escape of PDAC cells. (A) The protein expression of PD-L1 and CTLA-4 in PDAC cells. (B) Surviving PDAC cells examined using crystal violet staining. (C) The levels of IFN-γ and TNF-α, the immune effectors released by T cells, examined by ELISA. (D) Volume changes of xenograft tumors. (E) Weight of xenograft tumors. (F) Immunohistochemical detection of CD8+ T cell infiltration and expression of PD-L1 and CTLA-4 in xenograft tumors. *P < 0.05. Data are shown as mean ± SD of three technical replicates (n = 5). One-way (B, E) or two-way ANOVA (A, C, D, F) were used for data comparison.

Journal: American Journal of Cancer Research

Article Title: Circ_0006790 carried by bone marrow mesenchymal stem cell-derived exosomes regulates S100A11 DNA methylation through binding to CBX7 in pancreatic ductal adenocarcinoma

doi:

Figure Lengend Snippet: The circ_6790/CBX7/S100A11 axis regulates immune escape of PDAC cells. (A) The protein expression of PD-L1 and CTLA-4 in PDAC cells. (B) Surviving PDAC cells examined using crystal violet staining. (C) The levels of IFN-γ and TNF-α, the immune effectors released by T cells, examined by ELISA. (D) Volume changes of xenograft tumors. (E) Weight of xenograft tumors. (F) Immunohistochemical detection of CD8+ T cell infiltration and expression of PD-L1 and CTLA-4 in xenograft tumors. *P < 0.05. Data are shown as mean ± SD of three technical replicates (n = 5). One-way (B, E) or two-way ANOVA (A, C, D, F) were used for data comparison.

Article Snippet: The sections were sealed with 5% BSA at 37°C for 30 min and incubated overnight at 4°C with primary antibodies to CD8 (1:2000, ab209775, Abcam), PD-L1 (1:1.000, ab237726, Abcam), and CTLA-4 (1:500, ab237712, Abcam).

Techniques: Expressing, Staining, Enzyme-linked Immunosorbent Assay, Immunohistochemical staining